Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | TDO2 | P48775 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7130240 | 0.79 | IDO1 (0.35) | KDM4EIDO1TDO2TDP1ALDH1A1 | |
| SCHEMBL7126089 | 0.78 | ALDH1A1 (0.32) | POLBALDH1A1 | |
| SCHEMBL9908411 | 0.77 | ALDH1A1 (0.32) | KDM4EALDH1A1LMNA | |
| SCHEMBL14182366 | 0.75 | — | — | |
| SCHEMBL13992892 | 0.72 | — | — | |
| SCHEMBL7119984 | 0.70 | KDM4E (0.32) | KDM4ELMNA | |
| SCHEMBL3366580 | 0.68 | KDM4E (0.34) | KDM4EPOLBALOX15TDP1ALDH1A1 | |
| SCHEMBL14761258 | 0.67 | KDM4E (0.34) | KDM4EPOLBALOX15TDP1ALDH1A1 | |
| SCHEMBL12634093 | 0.66 | KDM4E (0.36) | KDM4EPOLBALOX15IDO1TDO2 | |
| SCHEMBL32688903 | 0.66 | KDM4E (0.40) | KDM4EPOLBALOX15IDO1TDO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6660448-B2 | Lactone ring-substituted norbornene based polymers; photoresists; resolution, etching resistance, use in micropatterning with electron beams or deep-ultraviolet radation | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2003-12-09 | — | — | US | disclosed |
| US-6500961-B2 | MICROSTRUCTURE PATTERNS FOR PHOTORESISTS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-12-31 | — | — | US | disclosed |
| US-20020091215-A1 | Polymer, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-07-11 | — | — | US | disclosed |
| US-20020019545-A1 | Novel lactone compounds having alicyclic structure and their manufacturing method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019545-A1 | Novel lactone compounds having alicyclic structure and their manufacturing method | RACK1, MRPS22, ECH1 | KDM4E 788/4885POLB 2115/4885ALOX15 66/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.